Based on the provided information from the CDC's weekly flu surveillance reports, the following key facts regarding predicting future ILI occurrence can be summarized:

1. Virologic Surveillance:
- Clinical laboratories reported that 3.1% of respiratory specimens tested positive for influenza viruses.
- Influenza A viruses (H3N2 and H1N1) and Influenza B viruses were detected in the specimens.
- Public health labs monitored the proportion of circulating viruses for each influenza subtype/lineage.

2. Outpatient Illness Surveillance:
- 1.4% of visits to healthcare providers were for ILI, which is below the national baseline of 2.4%.
- ILI activity varied across regions, with most reporting minimal activity, except for Louisiana experiencing moderate activity.

3. Geographic Spread:
- Four out of 53 jurisdictions reported local flu activity, while the rest reported sporadic or no flu activity.

4. Severe Disease:
- Hospitalization rates were not provided for the reported period.
- 5.0% of deaths were attributed to pneumonia and influenza (P&I), below the epidemic threshold of 5.6%.
- No influenza-associated pediatric deaths were reported for the current season.

5. Virus Characterization:
- Information on influenza virus characterization, including genetic and antigenic properties and resistance to antiviral medications, was not available for the reported period.

6. Recommendations:
- CDC expects flu activity to remain low but increase in the coming weeks.
- Annual flu vaccination is recommended for everyone aged 6 months and older.
- Antiviral drugs can be used to treat flu illness.

Overall, the surveillance reports provide data on the prevalence and circulation of influenza viruses, ILI activity, geographic spread, severe disease outcomes, and public health recommendations. These factors assist in predicting future ILI occurrence and guide preventive measures.